Empresas›ATOS
ATOS · ATOSSA THERAPEUTICS, INC.
preparados farmaceuticos · CIK 0001488039
- Caja
- no publicable
- Dilucion
- sin datos
- Ultimo documento
- 7 ago 2026
faltan datos o hay una emision posterior a la ultima cifra de caja conocida
hacen falta dos recuentos de acciones
Hecho relevante
Documentos presentados ante la SEC
2026
- 8-KHecho relevanteEDGAR
- 10-QInforme trimestralEDGAR
Duda sustancial sobre la continuidad de la empresa
…al to fund operating losses until it becomes profitable. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include an…
Contrasplit de acciones
…the Company’s estimates. 7 Reverse Stock Split On February 2, 2026, the Company effected a 1-for-15 reverse stock split of its issued and outstanding common stock (the Reverse Stock Split). As a resu…
Programa de venta continua de acciones (ATM)
…million. 2026 At the Market Offering Facility On February 20, 2026, the Company entered into an At the Market Offering Agreement, dated February 20, 2026 (the Sales Agreement), with Rodman & Renshaw…